Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.

Hueb W, Soares PR, Gersh BJ, César LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JA.

J Am Coll Cardiol. 2004 May 19;43(10):1743-51.

3.

Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?

Mehta RH, Lopes RD, Ballotta A, Frigiola A, Sketch MH Jr, Bossone E, Bates ER.

Am Heart J. 2010 Jan;159(1):141-7. doi: 10.1016/j.ahj.2009.10.035. Review.

PMID:
20102880
4.

PCI versus CABG versus medical therapy in 2006.

Morrison D.

Minerva Cardioangiol. 2006 Oct;54(5):643-72. Review.

PMID:
17019400
5.

Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.

Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R, Kapoor JR, Ardehali R, Owens DK, Hlatky MA.

Ann Intern Med. 2007 Nov 20;147(10):703-16. Epub 2007 Oct 15. Review.

PMID:
17938385
7.

Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.

Sobel BE.

Coron Artery Dis. 2010 May;21(3):189-98. doi: 10.1097/MCA.0b013e3283383ebe. Review.

PMID:
20308880
8.

Multivessel percutaneous coronary intervention: a new paradigm for a new century.

Morrison DA.

Minerva Cardioangiol. 2005 Oct;53(5):361-77. Review.

PMID:
16179881
9.
10.

Coronary artery stents: a rapid systematic review and economic evaluation.

Hill R, Bagust A, Bakhai A, Dickson R, Dündar Y, Haycox A, Mujica Mota R, Reaney A, Roberts D, Williamson P, Walley T.

Health Technol Assess. 2004 Sep;8(35):iii-iv, 1-242. Review.

11.

Coronary revascularization in multivessel disease. Which is better, stents or surgery?

Almeda FQ, Snell RJ.

Postgrad Med. 2005 Dec;118(6):11-7. Review.

PMID:
16382760
12.

Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.

Holper EM, Addo T.

Coron Artery Dis. 2010 Nov;21(7):397-401. doi: 10.1097/MCA.0b013e32833d0134. Review.

PMID:
20634692
14.

Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.

Simoons ML, Windecker S.

Eur Heart J. 2010 Mar;31(5):530-41. doi: 10.1093/eurheartj/ehp605. Epub 2010 Jan 26. Review.

PMID:
20106842
15.

Optimal method of coronary revascularization in patients receiving dialysis: systematic review.

Nevis IF, Mathew A, Novick RJ, Parikh CR, Devereaux PJ, Natarajan MK, Iansavichus AV, Cuerden MS, Garg AX.

Clin J Am Soc Nephrol. 2009 Feb;4(2):369-78. doi: 10.2215/CJN.02640608. Review.

16.

Clinical trials of revascularization therapy in diabetics.

Brooks RC, Detre KM.

Curr Opin Cardiol. 2000 Jul;15(4):287-92. Review.

PMID:
11139093
17.

Clinical trials of coronary revascularization: coronary angioplasty vs. coronary bypass grafting.

Bourassa MG.

Curr Opin Cardiol. 2000 Jul;15(4):281-6. Review.

PMID:
11139092
18.

Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications.

Ito H.

Gen Thorac Cardiovasc Surg. 2011 Jan;59(1):6-13. doi: 10.1007/s11748-010-0648-1. Epub 2011 Jan 12. Review.

PMID:
21225393
19.
20.

Cost-effective management of chronic stable angina.

O'Rourke RA.

Clin Cardiol. 1996 Jun;19(6):497-501. Review.

Supplemental Content

Support Center